Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

Arighno Das; Ahmed Gabr; Daniel P. O'Brian; Ahsun Riaz; Kush Desai; Bartley Thornburg; Joseph R. Kallini; Samdeep Mouli; Robert J. Lewandowski; Riad Salem

doi:10.1016/j.jvir.2019.07.020

Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

Arighno Das, Ahmed Gabr, Daniel P. O'Brian, Ahsun Riaz, Kush Desai, Bartley Thornburg, Joseph R. Kallini, Samdeep Mouli, Robert J. Lewandowski, Riad Salem^*

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Health-related quality of life has become an important aspect in oncologic decision making. Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an important prognostic role in patients with hepatocellular carcinoma (HCC). Locoregional therapies (LRTs) such as radiofrequency ablation, transarterial chemoembolization, and radioembolization (TARE) are important parts of HCC management. Results demonstrated that radiofrequency ablation treatment results in improving HRQoL compared to surgery for up to 3 years after treatment. Between TARE and transarterial chemoembolization, TARE provides the most benefit in terms of HRQoL. This systematic review investigated contemporary data surrounding HRQoL in patients undergoing LRTs and its impact on clinical decision making.

Original language	English (US)
Pages (from-to)	1924-1933.e2
Journal	Journal of Vascular and Interventional Radiology
Volume	30
Issue number	12
DOIs	https://doi.org/10.1016/j.jvir.2019.07.020
State	Published - Dec 2019

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jvir.2019.07.020

Cite this

Das, A., Gabr, A., O'Brian, D. P., Riaz, A., Desai, K., Thornburg, B., Kallini, J. R., Mouli, S., Lewandowski, R. J., & Salem, R. (2019). Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma. Journal of Vascular and Interventional Radiology, 30(12), 1924-1933.e2. https://doi.org/10.1016/j.jvir.2019.07.020

@article{b3a7b2091a6a4b12ab9b302cf1682d7d,

title = "Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma",

abstract = "Health-related quality of life has become an important aspect in oncologic decision making. Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an important prognostic role in patients with hepatocellular carcinoma (HCC). Locoregional therapies (LRTs) such as radiofrequency ablation, transarterial chemoembolization, and radioembolization (TARE) are important parts of HCC management. Results demonstrated that radiofrequency ablation treatment results in improving HRQoL compared to surgery for up to 3 years after treatment. Between TARE and transarterial chemoembolization, TARE provides the most benefit in terms of HRQoL. This systematic review investigated contemporary data surrounding HRQoL in patients undergoing LRTs and its impact on clinical decision making.",

author = "Arighno Das and Ahmed Gabr and O'Brian, {Daniel P.} and Ahsun Riaz and Kush Desai and Bartley Thornburg and Kallini, {Joseph R.} and Samdeep Mouli and Lewandowski, {Robert J.} and Riad Salem",

note = "Publisher Copyright: {\textcopyright} 2019 SIR",

year = "2019",

month = dec,

doi = "10.1016/j.jvir.2019.07.020",

language = "English (US)",

volume = "30",

pages = "1924--1933.e2",

journal = "Journal of Vascular and Interventional Radiology",

issn = "1051-0443",

publisher = "Elsevier Inc.",

number = "12",

}

Das, A, Gabr, A, O'Brian, DP, Riaz, A , Desai, K , Thornburg, B, Kallini, JR, Mouli, S , Lewandowski, RJ & Salem, R 2019, 'Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma', Journal of Vascular and Interventional Radiology, vol. 30, no. 12, pp. 1924-1933.e2. https://doi.org/10.1016/j.jvir.2019.07.020

TY - JOUR

T1 - Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

AU - Das, Arighno

AU - Gabr, Ahmed

AU - O'Brian, Daniel P.

AU - Riaz, Ahsun

AU - Desai, Kush

AU - Thornburg, Bartley

AU - Kallini, Joseph R.

AU - Mouli, Samdeep

AU - Lewandowski, Robert J.

AU - Salem, Riad

PY - 2019/12

Y1 - 2019/12

N2 - Health-related quality of life has become an important aspect in oncologic decision making. Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an important prognostic role in patients with hepatocellular carcinoma (HCC). Locoregional therapies (LRTs) such as radiofrequency ablation, transarterial chemoembolization, and radioembolization (TARE) are important parts of HCC management. Results demonstrated that radiofrequency ablation treatment results in improving HRQoL compared to surgery for up to 3 years after treatment. Between TARE and transarterial chemoembolization, TARE provides the most benefit in terms of HRQoL. This systematic review investigated contemporary data surrounding HRQoL in patients undergoing LRTs and its impact on clinical decision making.

AB - Health-related quality of life has become an important aspect in oncologic decision making. Recent data suggest that Health-Related Quality of Life (HRQoL) measurements can play an important prognostic role in patients with hepatocellular carcinoma (HCC). Locoregional therapies (LRTs) such as radiofrequency ablation, transarterial chemoembolization, and radioembolization (TARE) are important parts of HCC management. Results demonstrated that radiofrequency ablation treatment results in improving HRQoL compared to surgery for up to 3 years after treatment. Between TARE and transarterial chemoembolization, TARE provides the most benefit in terms of HRQoL. This systematic review investigated contemporary data surrounding HRQoL in patients undergoing LRTs and its impact on clinical decision making.

UR - http://www.scopus.com/inward/record.url?scp=85074389632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074389632&partnerID=8YFLogxK

U2 - 10.1016/j.jvir.2019.07.020

DO - 10.1016/j.jvir.2019.07.020

M3 - Review article

C2 - 31685362

AN - SCOPUS:85074389632

SN - 1051-0443

VL - 30

SP - 1924-1933.e2

JO - Journal of Vascular and Interventional Radiology

JF - Journal of Vascular and Interventional Radiology

IS - 12

ER -

Contemporary Systematic Review of Health-Related Quality of Life Outcomes in Locoregional Therapies for Hepatocellular Carcinoma

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this